Anavex Life Sciences Corp.
AVXL· Nasdaq
Filed Dec 22, 2011 · 10-K · 83 days after period end · 0001062993-11-005004
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$1.87M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Dec 22, 2011 · 83 d after period end